These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35266425)
41. Gemini curcumin inhibits 4T1 cancer cell proliferation and modulates the expression of apoptotic and metastatic genes in Balb/c mice model. Kandjani BZ; Hesari FS; Babaei E Pathol Res Pract; 2023 Mar; 243():154344. PubMed ID: 36738519 [TBL] [Abstract][Full Text] [Related]
42. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro. Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114 [TBL] [Abstract][Full Text] [Related]
43. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines. Mandalapu D; Saini KS; Gupta S; Sharma V; Yaseen Malik M; Chaturvedi S; Bala V; Hamidullah ; Thakur S; Maikhuri JP; Wahajuddin M; Konwar R; Gupta G; Sharma VL Bioorg Med Chem Lett; 2016 Sep; 26(17):4223-32. PubMed ID: 27496212 [TBL] [Abstract][Full Text] [Related]
45. Dehydrozingerone, a Curcumin Analog, as a Potential Anti-Prostate Cancer Inhibitor In Vitro and In Vivo. Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Sakorn N; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P Molecules; 2020 Jun; 25(12):. PubMed ID: 32545675 [TBL] [Abstract][Full Text] [Related]
46. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models. Badr G; Al-Sadoon MK; Rabah DM Free Radic Biol Med; 2013 Dec; 65():175-189. PubMed ID: 23811005 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo. Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862 [TBL] [Abstract][Full Text] [Related]
48. Scorpion Venom Causes Apoptosis by Increasing Reactive Oxygen Species and Cell Cycle Arrest in MDA-MB-231 and HCT-8 Cancer Cell Lines. Al-Asmari AK; Riyasdeen A; Islam M J Evid Based Integr Med; 2018; 23():2156587217751796. PubMed ID: 29405760 [TBL] [Abstract][Full Text] [Related]
49. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo. Moghtaderi H; Sepehri H; Attari F Biomed Pharmacother; 2017 Apr; 88():582-594. PubMed ID: 28152473 [TBL] [Abstract][Full Text] [Related]
50. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Ruttala HB; Ko YT Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481 [TBL] [Abstract][Full Text] [Related]
51. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro. Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664 [TBL] [Abstract][Full Text] [Related]
52. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer. Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247 [TBL] [Abstract][Full Text] [Related]
53. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738 [TBL] [Abstract][Full Text] [Related]
54. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells. Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522 [TBL] [Abstract][Full Text] [Related]
55. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas. Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193 [TBL] [Abstract][Full Text] [Related]
56. Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line. Moradi M; Najafi R; Amini R; Solgi R; Tanzadehpanah H; Esfahani AM; Saidijam M Cell Biol Toxicol; 2019 Aug; 35(4):373-385. PubMed ID: 30617443 [TBL] [Abstract][Full Text] [Related]
57. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers. Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000 [TBL] [Abstract][Full Text] [Related]
58. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Patil S; Choudhary B; Rathore A; Roy K; Mahadik K Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533 [TBL] [Abstract][Full Text] [Related]
59. Curcumin enhances the anti-cancer effects of Paris Saponin II in lung cancer cells. Man S; Zhang L; Cui J; Yang L; Ma L; Gao W Cell Prolif; 2018 Aug; 51(4):e12458. PubMed ID: 29608021 [TBL] [Abstract][Full Text] [Related]
60. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]